Top Markets
#1 Bitway Bitway +46.14%
#2 Wrapped STX (Velar) Wrapped STX (Velar) +41.04%
#3 Pons Pons +35.97%
#4 Starpower Starpower +35.36%
#5 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +27.38%
#6 Ocean Protocol Ocean Protocol +20.20%
#7 SkyAI SkyAI +18.33%
#8 Mubarak Mubarak +18.32%
#9 StonkBroker StonkBroker +16.81%
#10 aelf aelf +16.32%
Coin of the day
Bitway Bitway
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Human Metabolome Technologies, Inc. Human Metabolome Technologies, Inc.

Human Metabolome Technologies, Inc.

6090
Classifica tra le azioni #29370
Human Metabolome Technologies, Inc. is a biotechnology company based in... Human Metabolome Technologies, Inc. is a biotechnology company based in Tsuruoka, Japan, established in 2003. It focuses on developing and providing metabolomics technologies and solutions for a range of applications, including drug discovery, disease diagnosis, and food production primarily within Japan. The company offers a comprehensive suite of metabolome analysis services, encompassing global profiling, targeted assays, flux analysis, and lipidomics. Additionally, it develops biomarkers, such as Phosphorylethanolamine, which is measured in blood plasma as a marker for major depressive disorder. HMT's solutions address diverse areas like cancer metabolism, infectious diseases, basic and clinical research, food and nutrition, and microbiome studies. The company also fosters collaborations, notably with the Institute for Advanced Biosciences and Keio University, to further advance metabolome analysis technology.
Prezzo delle azioni
$3.86
Capitalizzazione di mercato
$21.49M
Variazione (1 giorno)
-0.17%
Variazione (1 anno)
-25.27%
Paese
JP
Scambia Human Metabolome Technologies, Inc. (6090)

Categoria

Healthcare
Ricavi di Human Metabolome Technologies, Inc. (6090)
Ricavi nel Aug 2026 TTM: 0
Secondo gli ultimi rapporti finanziari di Human Metabolome Technologies, Inc., i ricavi attuali dell'azienda (TTM) sono pari a 0. Nel 2026, l'azienda ha registrato ricavi di 0 uguale a i ricavi dell'anno 2026, che erano pari a 0. I ricavi rappresentano l'importo totale generato dalla vendita di beni o servizi. A differenza degli utili, le spese non vengono detratte.
Storico dei ricavi per Human Metabolome Technologies, Inc. da 2026 a 2026
Ricavi alla fine di ogni anno
Anno Ricavi Cambia
Non abbastanza dati per le date fornite.
Ricavi di aziende simili o concorrenti
Azienda Ricavi Differenza nei ricavi Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH